Ireland
--:--IST
Latest
Clinical Trials in Switzerland / NCT06308055
Recruiting Observational

Abiomed Impella RT-DAQ - Observational Study

NCT06308055 · tracked via the Priya Life Science Switzerland tracker
Phase
Observational
Started
2024-10-04
Last updated
2026-06-17

Condition(s) studied

Cardiogenic Shock

Investigational drug(s) / intervention(s)

Data Acquisition

Data Acquisition: Develop algorithms for determining the cardiac output through the synchronous acquisition of hemodynamic data from the pulmonary artery catheter or other pressure sensors and Impella using a network module.

Study summary

Abiomed IMPELLA-RT-DAQ - Impella Real Time Data AcQuisition

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Ongoing or planned intensive care management with Impella support 2. Presence or planned placement of a cardiac output measurement 1. Preferentially pulmonary catheter (including cardiac output (CO) preferred as continuous measurement) 2. Other means of discontinuous CO measurement incl. echocardiography, other thermodilution methods Exclusion Criteria: 1. Age \< 18 years 2. Pregnancy 3. Anticipated support duration \<24 h

Primary outcome measure(s)

Trial sites (4)

FacilityCityRegionStatus
Uniklinik RWTH Aachen Aachen North Rhine-Westphalia Active Not Recruiting
UKSH Campus Kiel Kiel Schleswig-Holstein Not Yet Recruiting
IRCCS Ospedale San Raffaele Milan MI Not Yet Recruiting
Universitätsspital Basel Basel Switzerland Recruiting

More Abiomed Inc. trials in Switzerland

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06308055 on ClinicalTrials.gov ↗ ← All trials in Switzerland